default author photo

Sarah R. Leist

University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology

United States

  • University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology

SCHOLARLY PAPERS

2

DOWNLOADS

105

TOTAL CITATIONS

13

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022

Number of pages: 15 Posted: 01 Jun 2020
Caroline Atyeo, Matthew D. Slein, Stephanie Fischinger, John Burke, Alexandra Schӓfer, Sarah R. Leist, Anna Honko, Rebecca Johnson, Nadia Storm, Matthew Bernett, Caitlyn Linde, Todd Suscovich, Anthony Griffiths, John R. Desjarlais, Boris D. Juelg, Jaap Goudsmit, Ralph Baric and Galit Alter
Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Boston University - Department of Microbiology, Boston University - Department of Microbiology, Boston University - Department of Microbiology, Xencor, SeromYx Systems, SeromYx Systems, Boston University - Department of Microbiology, Xencor, Ragon Institute of MGH, MIT and Harvard, Harvard University - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology and Ragon Institute of MGH, MIT and Harvard
Downloads 62 (942,565)
Citation 1

Abstract:

Loading...

SARS-CoV-2, antibody effector function, immunity, Fc function, CR3022

2.

Remdesivir Potently Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Number of pages: 28 Posted: 11 May 2020
Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinksi, Kenneth H. Dinnon, Boyd L. Yount, Maria L. Agostini, Laura J. Stevens, James D. Chappell, Xiaotao Lu, Tia M. Hughes, Kendra Gully, David Martinez, Ariane J. Brown, Rachel L. Graham, Jason K. Perry, Venice Du Pont, Jared Pitts, Bin Ma, Darius Babusis, Eisuke Murakami, Joy Y. Feng, John P. Bilello, Danielle Porter, Tomas Cihlar, Ralph S. Baric, Mark R. Denison and Timothy P. Sheahan
Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Vanderbilt University - Department of Pediatrics and University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology
Downloads 43 (1,145,425)
Citation 12

Abstract:

Loading...

COVID-19, SARS-Cov-2, coronavirus, antivirals, remdesivir, RdRp, RNA-dependent RNA polymerase, therapeutic, mouse